Evidence map›Paper›PMID 39914521›Full record

ArticleNeuroscience2025

Sleep and circadian rhythm activity alterations during adolescence in a mouse model of neonatal fentanyl withdrawal syndrome.

Benjamin R Williams, Mackenzie C Gamble, Navsharan Singh, Camron D Bryant, Beth A Logan, Ryan W Logan

Abstract read
In one paragraph

Article in Neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Benjamin R WilliamsDepartment of Psychiatry, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Mackenzie C GambleMolecular and Translational Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA; Department of Pharmacology, Biochemistry & Biophysics, Boston University School of Medicine, Boston, MA, USA.
Navsharan SinghDepartment of Pharmacology, Biochemistry & Biophysics, Boston University School of Medicine, Boston, MA, USA.
Camron D BryantSchool of Pharmacy and Pharmaceutical Sciences, Bouvé College of Health Sciences, Northeastern University, Boston, MA, USA.
Beth A LoganPsychiatry Consultation Service, Department of Psychiatry and Behavioral Sciences, Boston Children's Hospital, Boston, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Ryan W LoganDepartment of Psychiatry, University of Massachusetts Chan Medical School, Worcester, MA, USA; Department of Pharmacology, Biochemistry & Biophysics, Boston University School of Medicine, Boston, MA, USA; Department of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, USA. Electronic address: ryan.logan@umassmed.edu.

Funding

Cell-type specific role of circadian-dependent transcription in fentanyl-induced synaptic and behavioral plasticity - SupplementR01HL150432 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LOGAN, RYAN W · 2019 to 2020
$2.0M
Novel roles for the circadian transcription factor NPAS2 and striatal dopamine D3 receptor signaling in diurnal fentanyl craving and relapseR01DA061243 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ZACHARY FREYBERG, Ryan W Logan · 2024 to 2026
$1.4M
Generating novel mouse tools to investigate brain region and cell-type specific circadian molecular mechanisms of reward and motivationR33DA041872 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LOGAN, RYAN W · 2018 to 2020
$1.1M
Graduate Training at the Interface of Neuroscience, Optical Engineering and Data ScienceT32NS136080 · NINDS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI David A Boas, Jerry L Chen · 2024 to 2026
$661k
The role of the circadian transcription factor NPAS2 in the nucleus accumbens to regulate cocaine rewardK01DA038654 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LOGAN, RYAN W · 2015 to 2018
$626k
Generating novel mouse tools to investigate brain region and cell-type specific circadian molecular mechanisms of reward and motivationR21DA041872 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LOGAN, RYAN W, MCCLUNG, COLLEEN A · 2016 to 2017
$379k
NHLBI NIH HHS R01 HL150432NIDA NIH HHS K01 DA038654NIDA NIH HHS R01 DA061243NIDA NIH HHS R21 DA041872NIDA NIH HHS R33 DA041872NINDS NIH HHS T32 NS136080
6 · The paper itself

Abstract

Fentanyl, a highly potent synthetic opioid, is a major contributor to the ongoing opioid epidemic. During adulthood, fentanyl is known to induce pronounced sleep and circadian disturbances during use and withdrawal. Children exposed to opioids in utero are likely to develop neonatal opioid withdrawal syndrome, and display sleep disturbances after birth. However, it is currently unknown how neonatal opioid withdrawal from fentanyl impacts sleep and circadian rhythms in mice later in life. To model neonatal opioid withdrawal syndrome, mice were treated with fentanyl from postnatal days 1 through 14, analogous to the third trimester of human gestation. After weaning, fentanyl and saline treated mice underwent non-invasive sleep and circadian rhythm monitoring during adolescence postnatal days 23 through 30. Neonatal fentanyl exposure led to an increase in the percent time spent in rapid eye movement sleep across days. Thus, neonatal fentanyl exposure leads to altered sleep-wake states during adolescence in mice.

Indexed as

Analgesics, OpioidCircadian RhythmFentanylNeonatal Abstinence SyndromeSleepSleep Wake DisordersSubstance Withdrawal SyndromeAnimalsAnimals, NewbornDisease Models, AnimalFemaleMaleMiceMice, Inbred C57BLAnalgesics, OpioidFentanylCircadianFentanylNeonatalOpioidsSleep

Identifiers

PMID39914521
PMCPMC11884988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.